Coherus BioSciences to Report Second Quarter 2022 Financial Results on August 4th, 2022

On July 28, 2022 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), reported that its second quarter 2022 financial results will be released after market close on Thursday, August 4th, 2022 (Press release, Coherus Biosciences, JUL 28, 2022, View Source [SID1234617116]). Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

After releasing second quarter 2022 financial results, the Company will post them on the Coherus website at View Source

Webcast: View Source

Please dial-in 15 minutes early to ensure a timely connection to the call.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!